The Effect Of AVANDIA On The Late Asthmatic Response

• Status: Completed
• Trial end date: 2006-06-30
• Target enrollment: 0
• Participant gender: All

Summary

This study is to investigate the effects of AVANDIA on the asthmatic response.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Rosiglitazone

Criteria

Inclusion criteria:

• Mild asthmatic treated with short-acting beta agonists only, non-smoker.

Exclusion criteria:

• Inability to abstain from medications other than short-acting beta agonists and paracetamol.

• Recent administration of steroids.

• Recent respiratory infection or exacerbation of asthma.